Sutro Biopharma Inc (STRO)
3.895
+0.06
(+1.70%)
USD |
NASDAQ |
May 06, 16:00
3.895
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Debt to Equity Ratio: 0.0271 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0271 |
| September 30, 2023 | 0.0635 |
| June 30, 2023 | 0.0659 |
| March 31, 2023 | 0.0714 |
| December 31, 2022 | 0.075 |
| September 30, 2022 | 0.0839 |
| June 30, 2022 | 0.1066 |
| March 31, 2022 | 0.1146 |
| December 31, 2021 | 0.0994 |
| September 30, 2021 | 0.088 |
| June 30, 2021 | 0.0807 |
| March 31, 2021 | 0.0803 |
| December 31, 2020 | 0.0739 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.10 |
| June 30, 2020 | 0.1174 |
| March 31, 2020 | 0.2943 |
| December 31, 2019 | 0.101 |
| September 30, 2019 | 0.1032 |
| June 30, 2019 | 0.1071 |
| March 31, 2019 | 0.1091 |
| December 31, 2018 | 0.1119 |
| September 30, 2018 | -0.1038 |
| June 30, 2018 | -0.1121 |
| March 31, 2018 | |
| December 31, 2017 | -0.1336 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0271
Minimum
Dec 2023
0.2943
Maximum
Mar 2020
0.0975
Average
0.088
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| AnaptysBio Inc | 0.00 |
| ABVC BioPharma Inc | 0.1751 |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 0.3015 |
| Journey Medical Corp | 0.7185 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 470.74M |
| Total Liabilities (Quarterly) | 321.09M |
| Shareholders Equity (Quarterly) | 149.65M |
| Current Ratio | 4.497 |
| Net Debt Paydown Yield | 1.16% |